Crombet, T., Torres, L., Neninger, E., et al. (2003) Pharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients with Advanced Epithelial-Derived Cancer. Journal of Immunotherapy, 26, 139-148. http://dx.doi.org/10.1097/00002371-200303000-00006

has been cited by the following article:

• TITLE: Nimotuzumab in Treatment of Infiltrating Squamous Cell Carcinoma of Tongue

  AUTHORS: Alex A. Prasad

  KEYWORDS: Nimotuzumab, Epidermal Growth Factor Receptor (EGFR), Transforming Growth Factor α (TGFα)

  JOURNAL NAME: Journal of Cancer Therapy, Vol.6 No.2, January 30, 2015

  ABSTRACT: A 50-year male patient presented to outpatient department with a mass on tongue associated with pain. A plain computerised tomography scan done on 17/01/13 revealed mild growth on lateral border of tongue with an enlarged jugulo-digastric lymph node measuring 1.8×1 cm. Excision of tongue was done and sent for histopathological examination which revealed infiltrating squamous cell carcinoma. The patient was treated with 2 cycles of Induction chemotherapy with cisplatin and paclitaxel administered in q3w schedule. Induction chemotherapy was followed by concurrent chemoradiotherapy with 6 cycles of nimotuzumab 200 mg and cisplatin 20 mg given weekly along with 60 gy/30 fractions of radiation using IMRT. Latest CT scan done on 20/01/2014 revealed no evidence of disease (NED).